[Risk of thromboembolic complications and the peculiarities of anti-thrombotic treatment in patients with atrial sibrillium fibrillation.]
The article presents the results of a study of risk factors (FR) for the development of thromboembolic and hemorrhagic complications, the features of antithrombotic therapy (ATT) in patients of older age groups with non-valvular atrial fibrillation (AF) according to the hospital register of patients with AF of the clinic of the Medical Research Institute problems of the North (RIMPS). A detailed analysis of individual risk factors in patients on the CHA2DS2-VASc and HAS-BLED scales was performed. The leading risk factor for thromboembolic complications (in frequency) was arterial hypertension (AH), which occurred in 76,1% of all examined patients with AF, while in elderly and senile patients, the incidence of AH was higher compared with middle-aged patients. An analysis of the risk of thromboembolic complications (TEAS) in patients with AF on the CHA2DS2-VASc scale suggests that almost all patients in the older age groups, especially those of old age, have an increased risk of TEO and need prophylactic anticoagulant medication. Moreover, almost half (45%) of elderly patients have 6 or more points on the CHA2DS2-VASc scale. An analysis of the risk of hemorrhagic complications according to the HAS-BLED scale showed that the highest number of persons with a high risk of hemorrhagic complications was in elderly patients. ATT at the prehospital stage in persons of older age groups according to the RIMPS register is characterized by a low intake of KLA and a high intake of disaggregants. The main reasons for not accepting the OAK were: difficulties in controlling the INR when taking warfarin and the high cost of the PLA.